{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T05:16:01Z","timestamp":1794978961874,"version":"4.9.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T00:00:00Z","timestamp":1745712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T00:00:00Z","timestamp":1745712000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-00013-6","type":"journal-article","created":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T17:12:56Z","timestamp":1745773976000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["The biosensor using the target urine volatile organic compounds for detecting diabetic kidney disease"],"prefix":"10.1038","volume":"15","author":[{"given":"Chatchai","family":"Kreepala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vichayut Suthat Na","family":"Ayutaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rungrueang","family":"Phatthanakun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kittipong","family":"Thabsuwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jirayupa","family":"Paewponsong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,27]]},"reference":[{"issue":"15","key":"13_CR1","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1056\/NEJMcp011773","volume":"346","author":"G Remuzzi","year":"2002","unstructured":"Remuzzi, G., Schieppati, A. & Ruggenenti, P. Nephropathy in patients with type 2 diabetes. N. Engl. J. Med. 346 (15), 1145\u20131151 (2002).","journal-title":"N. Engl. J. Med."},{"key":"13_CR2","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s10792-014-0018-6","volume":"35","author":"P Kotlarsky","year":"2015","unstructured":"Kotlarsky, P. et al. Link between retinopathy and nephropathy caused by complications of diabetes mellitus type 2. Int. Ophthalmol. 35, 59\u201366 (2015).","journal-title":"Int. Ophthalmol."},{"issue":"3","key":"13_CR3","doi-asserted-by":"publisher","first-page":"116","DOI":"10.2337\/diaclin.29.3.116","volume":"29","author":"MJ Fowler","year":"2011","unstructured":"Fowler, M. J. Microvascular and macrovascular complications of diabetes. Clin. Diabetes. 29 (3), 116\u2013122 (2011).","journal-title":"Clin. Diabetes"},{"key":"13_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13098-015-0121-5","volume":"8","author":"MP Buffon","year":"2016","unstructured":"Buffon, M. P. et al. rs1888747 polymorphism in the FRMD3 gene, gene and protein expression: role in diabetic kidney disease. Diabetol. Metab. Syndr. 8, 1\u201310 (2016).","journal-title":"Diabetol. Metab. Syndr."},{"issue":"2","key":"13_CR5","doi-asserted-by":"publisher","first-page":"263","DOI":"10.23876\/j.krcp.20.190","volume":"40","author":"C Kreepala","year":"2021","unstructured":"Kreepala, C. et al. Manifestation of rs1888747 polymorphisms in the FRMD3 gene in diabetic kidney disease and diabetic retinopathy in type 2 diabetes patients. Kidney Res. Clin. Pract. 40 (2), 263 (2021).","journal-title":"Kidney Res. Clin. Pract."},{"key":"13_CR6","doi-asserted-by":"publisher","first-page":"688272","DOI":"10.3389\/fped.2021.688272","volume":"9","author":"RG Nijman","year":"2021","unstructured":"Nijman, R. G. et al. A novel framework for phenotyping children with suspected or confirmed infection for future biomarker studies. Front. Pead. 9, 688272 (2021).","journal-title":"Front. Pead."},{"issue":"8","key":"13_CR7","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1158\/1055-9965.EPI-08-0045","volume":"17","author":"HB Ketelslegers","year":"2008","unstructured":"Ketelslegers, H. B. et al. Multiplex genotyping as a biomarker for susceptibility to carcinogenic exposure in the FLEHS biomonitoring study. Cancer Epidemiol. Biomarkers Prev. 17 (8), 1902\u20131912 (2008).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"4","key":"13_CR8","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3233\/CBM-2012-00270","volume":"11","author":"Y Wang","year":"2012","unstructured":"Wang, Y. et al. The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines. Cancer Biomarkers. 11 (4), 129\u2013137 (2012).","journal-title":"Cancer Biomarkers"},{"key":"13_CR9","doi-asserted-by":"crossref","unstructured":"Schmidt, K. & Podmore, I. Current challenges in volatile organic compounds analysis as potential biomarkers of cancer. Journal of biomarkers. ;2015. (2015).","DOI":"10.1155\/2015\/981458"},{"issue":"4","key":"13_CR10","first-page":"232","volume":"7","author":"Q Gao","year":"2019","unstructured":"Gao, Q. & Lee, W-Y. Urinary metabolites for urological cancer detection: A review on the application of volatile organic compounds for cancers. Am. J. Clin. Experimental Urol. 7 (4), 232 (2019).","journal-title":"Am. J. Clin. Experimental Urol."},{"key":"13_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11306-018-1361-9","volume":"14","author":"D Rodrigues","year":"2018","unstructured":"Rodrigues, D. et al. Volatile metabolomic signature of bladder cancer cell lines based on gas chromatography\u2013mass spectrometry. Metabolomics 14, 1\u201315 (2018).","journal-title":"Metabolomics"},{"issue":"9","key":"13_CR12","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1111\/jcmm.13132","volume":"21","author":"M Monteiro","year":"2017","unstructured":"Monteiro, M. et al. GC\u2010MS metabolomics\u2010based approach for the identification of a potential VOC\u2010biomarker panel in the urine of renal cell carcinoma patients. J. Cell. Mol. Med. 21 (9), 2092\u20132105 (2017).","journal-title":"J. Cell. Mol. Med."},{"issue":"11","key":"13_CR13","doi-asserted-by":"publisher","first-page":"e0143283","DOI":"10.1371\/journal.pone.0143283","volume":"10","author":"T Khalid","year":"2015","unstructured":"Khalid, T. et al. Urinary volatile organic compounds for the detection of prostate cancer. PloS One. 10 (11), e0143283 (2015).","journal-title":"PloS One"},{"issue":"4","key":"13_CR14","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1159\/000478782","volume":"26","author":"M Wang","year":"2017","unstructured":"Wang, M., Xie, R., Jia, X. & Liu, R. Urinary volatile organic compounds as potential biomarkers in idiopathic membranous nephropathy. Med. Principles Pract. 26 (4), 375\u2013380 (2017).","journal-title":"Med. Principles Pract."},{"issue":"2","key":"13_CR15","doi-asserted-by":"publisher","first-page":"e531","DOI":"10.1210\/clinem\/dgad584","volume":"109","author":"X Duan","year":"2024","unstructured":"Duan, X. et al. Increased levels of urine volatile organic compounds are associated with diabetes risk and impaired glucose homeostasis. J. Clin. Endocrinol. Metabolism. 109 (2), e531\u2013e42 (2024).","journal-title":"J. Clin. Endocrinol. Metabolism"},{"issue":"1","key":"13_CR16","doi-asserted-by":"publisher","first-page":"3551","DOI":"10.1038\/s41598-024-54138-1","volume":"14","author":"V Suthat Na Ayutaya","year":"2024","unstructured":"Suthat Na Ayutaya, V. et al. Urinary cancer detection by the target urine volatile organic compounds biosensor platform. Sci. Rep. 14 (1), 3551 (2024).","journal-title":"Sci. Rep."},{"key":"13_CR17","doi-asserted-by":"publisher","first-page":"354","DOI":"10.3389\/fchem.2020.00354","volume":"8","author":"I \u015eerban","year":"2020","unstructured":"\u015eerban, I. & Enesca, A. Metal oxides-based semiconductors for biosensors applications. Front. Chem. 8, 354 (2020).","journal-title":"Front. Chem."},{"key":"13_CR18","doi-asserted-by":"publisher","first-page":"115690","DOI":"10.1016\/j.trac.2019.115690","volume":"121","author":"B Liu","year":"2019","unstructured":"Liu, B. & Liu, J. Sensors and biosensors based on metal oxide nanomaterials. TRAC Trends Anal. Chem. 121, 115690 (2019).","journal-title":"TRAC Trends Anal. Chem."},{"issue":"6","key":"13_CR19","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1053\/j.ajkd.2022.08.004","volume":"80","author":"HJ Kramer","year":"2022","unstructured":"Kramer, H. J. et al. An endorsement of the removal of race from GFR Estimation equations: a position statement from the National kidney foundation kidney disease outcomes quality initiative. Am. J. Kidney Dis. 80 (6), 691\u2013696 (2022).","journal-title":"Am. J. Kidney Dis."},{"issue":"19","key":"13_CR20","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","volume":"385","author":"LA Inker","year":"2021","unstructured":"Inker, L. A. et al. New creatinine-and Cystatin C\u2013based equations to estimate GFR without race. N. Engl. J. Med. 385 (19), 1737\u20131749 (2021).","journal-title":"N. Engl. J. Med."},{"issue":"Supplement_2","key":"13_CR21","doi-asserted-by":"publisher","first-page":"64","DOI":"10.2337\/diab.32.2.S64","volume":"32","author":"C Mogensen","year":"1983","unstructured":"Mogensen, C., Christensen, C. & Vittinghus, E. The stages in diabetic renal disease: with emphasis on the stage of incipient diabetic nephropathy. Diabetes 32 (Supplement_2), 64\u201378 (1983).","journal-title":"Diabetes"},{"issue":"4","key":"13_CR22","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1681\/ASN.2010010010","volume":"21","author":"TWC Tervaert","year":"2010","unstructured":"Tervaert, T. W. C. et al. Pathologic classification of diabetic nephropathy. J. Am. Soc. Nephrol. 21 (4), 556\u2013563 (2010).","journal-title":"J. Am. Soc. Nephrol."},{"key":"13_CR23","unstructured":"Ngamjarus, C. & Pattanittum, P. n4Studies Plus: Application for Sample Size Calculation in Health Science Research. Version 1.4 (App store, 2024)."},{"key":"13_CR24","unstructured":"Bernard, R. Fundamentals of Biostatistics 5th edn p384\u2013385 (Thomson learning, 2000)."},{"key":"13_CR25","unstructured":"Ngamjarus, C. Sample Size Calculation for Health Science Research 1st edn (Khon Kaen University Printing House, 2021)."},{"issue":"12","key":"13_CR26","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1016\/j.ekir.2020.09.007","volume":"5","author":"A Chedid","year":"2020","unstructured":"Chedid, A. et al. Low-level proteinuria in systemic lupus erythematosus. Kidney Int. Rep. 5 (12), 2333\u20132340 (2020).","journal-title":"Kidney Int. Rep."},{"issue":"44","key":"13_CR27","doi-asserted-by":"publisher","first-page":"e8154","DOI":"10.1097\/MD.0000000000008154","volume":"96","author":"YK Kee","year":"2017","unstructured":"Kee, Y. K. et al. Determination of the optimal target level of proteinuria in the management of patients with glomerular diseases by using different definitions of proteinuria. Medicine 96 (44), e8154 (2017).","journal-title":"Medicine"},{"issue":"15","key":"13_CR28","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1056\/NEJM197804132981507","volume":"298","author":"BM Brenner","year":"1978","unstructured":"Brenner, B. M., Hostetter, T. H. & Humes, H. D. Molecular basis of proteinuria of glomerular origin. N. Engl. J. Med. 298 (15), 826\u2013833 (1978).","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"13_CR29","doi-asserted-by":"publisher","first-page":"2258","DOI":"10.1016\/j.ekir.2021.07.029","volume":"6","author":"JA \u00d8stergaard","year":"2021","unstructured":"\u00d8stergaard, J. A. & Cooper, M. E. The discordance between the renal histopathology and clinical presentation of diabetic nephropathy calls for novel approaches for the prediction and monitoring of kidney failure in diabetes. Kidney Int. Rep. 6 (9), 2258\u20132260 (2021).","journal-title":"Kidney Int. Rep."},{"issue":"1","key":"13_CR30","doi-asserted-by":"publisher","first-page":"100569","DOI":"10.1016\/j.xkme.2022.100569","volume":"5","author":"L Zeng","year":"2023","unstructured":"Zeng, L. et al. Urinary and kidney podocalyxin and Podocin levels in diabetic kidney disease: a kidney biopsy study. Kidney Med. 5 (1), 100569 (2023).","journal-title":"Kidney Med."},{"issue":"1","key":"13_CR31","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3390\/metabo11010017","volume":"11","author":"Q Wen","year":"2020","unstructured":"Wen, Q., Boshier, P., Myridakis, A., Belluomo, I. & Hanna, G. B. Urinary volatile organic compound analysis for the diagnosis of cancer: A systematic literature review and quality assessment. Metabolites 11 (1), 17 (2020).","journal-title":"Metabolites"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-00013-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-00013-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-00013-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T17:12:58Z","timestamp":1745773978000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-00013-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,27]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["13"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-00013-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,27]]},"assertion":[{"value":"19 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14738"}}